Manufacturing & Bioprocessing - software & AI news

Daily news on software, AI, and companies shaping manufacturing & bioprocessing.

Showing 42 results
Minimalist illustration of a lab flask and Copenhagen skyline in dark colors with lime accents.

Jun 19, 2026

US biotech Anthology Biotechnologies establishes European headquarters in Copenhagen

Anthology Biotechnologies, a US-based biotech firm, has officially launched its European subsidiary in Copenhagen, marking a significant expansion into the European market.The company, founded in 2023 with ties to prestigious institutions like MIT, Boston University, and Harvard, aims to innovate biomanufacturing through the integration of genome engineering, hardware engineering, and artificial intelligence. The choice of Copenhagen as its European headquarters is strategic, given the region's
Flat illustration of a PCR test kit

Jun 18, 2026

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line

Co-Diagnostics is advancing its collaboration with CoMira Diagnostics, a joint venture in Saudi Arabia, by showcasing its automated manufacturing capabilities aimed at enhancing local diagnostic production.The recent visit by a CoMira delegation to Co-Diagnostics’ headquarters in Salt Lake City marks a significant step in the partnership, which focuses on transferring technology to improve healthcare diagnostics in Saudi Arabia and surrounding regions. The event featured a tour of the company's
A minimalist illustration of a pill and a broken pill on a solid background.

Jun 6, 2026

When validated systems lose trust: why cyber risk is a Pharma 5.0 safety issue

The evolution of pharmaceutical manufacturing under Pharma 5.0 raises critical concerns regarding trust in validated systems, especially in the context of cyber risks.Pharmaceutical manufacturing is heavily reliant on controlled environments, validated processes, and stringent regulatory oversight to ensure product quality and patient safety. However, as the industry transitions to Pharma 5.0, which integrates automation, AI, and advanced analytics, the foundation of this trust is being challeng
A flat illustration of a protein structure in a minimalist style.

Jun 5, 2026

India’s biofoundry bet: Can the country leap into the AI–biotech race?

India is positioning itself in the competitive landscape of AI-driven biotechnology, aiming to establish robust biofoundries and biomanufacturing capabilities.A global shift is occurring as countries race to harness the potential of artificial intelligence in biological research. AI's ability to design proteins and biological systems at unprecedented speeds has highlighted a critical need for automated experimental platforms that can translate these designs into tangible products. India is respo
A glass vial with a colorful drug compound on a lab bench, surrounded by blurred lab equipment.

Jun 5, 2026

Day three preview: the Future of Bio/Pharma Analysis Virtual Summit 2026

Day three of the Future of Bio/Pharmaceutical Analysis Virtual Summit 2026 will spotlight innovations in pharmaceutical manufacturing, emphasizing the role of digital technologies and AI in transforming the industry.Scheduled for June 25, 2026, this segment of the summit will convene experts from academia, industry, and technology to tackle the challenges of translating innovative manufacturing techniques into actionable strategies. The day features three sessions, each addressing different aspe
A debug tool on a workbench with circuit boards in a dimly lit workshop.

Jun 5, 2026

Improving Defect Analysis and Quality Control with AI Diagnostics

Jabil's recent collaboration with Siemens Mendix and AWS has significantly enhanced its manufacturing diagnostics through the implementation of an AI-powered Debug Tool Assistant.The manufacturing sector faces challenges such as production defects that can lead to revenue loss and customer dissatisfaction. Jabil, a global leader in the industry, recognized that its technicians were spending a substantial amount of time sifting through fragmented information to diagnose issues. This inefficiency
A vial of vaccine and a syringe in a dimly lit lab setting.

May 27, 2026

Ahmedabad Pharma Digital Transformation Sparks Big Hope

The pharmaceutical industry in India is undergoing a significant digital transformation, driven by the need for enhanced production efficiency and compliance with global standards.India, often referred to as the "Pharmacy of the World," is a major player in the global pharmaceutical landscape, supplying around 20% of the world's generic medicines and over half of its vaccines. As demand for faster production and better tracking systems increases, the sector is embracing digital technologies, aut
Minimalist illustration of a cell and gene therapy concept

May 26, 2026

Europe Pharmaceutical CDMO Market Forecast to Hit USD 94.94 Billion by 2035 as Biologics, AI-Powered Manufacturing, and Advanced Therapies Redefine Drug Outsourcing

The European Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market is poised for significant growth, projected to reach approximately USD 94.94 billion by 2035, up from USD 49.06 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.59% during this period.This expansion is largely driven by the increasing demand for personalized therapies, particularly in the realm of cell and gene therapies, alongside the complexities of biologics development. The mark
A cardboard box of pharmaceuticals in a dimly lit warehouse

May 15, 2026

How AI Fits Into the Pharmaceutical Supply Chain

The integration of artificial intelligence (AI) into the pharmaceutical supply chain is evolving rapidly, driven by the need to address significant challenges such as drug shortages and supply chain disruptions. As the market for AI in pharmaceuticals is projected to surge from $4 billion to $25.7 billion by 2030, its applications extend beyond drug discovery to critical areas like manufacturing and logistics.Current supply chain issues, including a record number of drug shortages in the U.S. an
A minimalist illustration of a cell and a boardroom table in a life sciences context.

May 11, 2026

iOrganBio Appoints AI and Life Sciences Investor Jessica Owens to Its Board of Directors

iOrganBio has announced the appointment of Jessica Owens to its Board of Directors, bringing her extensive experience in life sciences and AI to the forefront of its operations.With over 20 years in company-building and investment, Owens is recognized for her role in co-founding GRAIL, which successfully secured over $1 billion in funding and formed strategic partnerships with major pharmaceutical companies like Bristol Myers Squibb, Merck, and Johnson & Johnson. Her expertise is expected to be
A vial of CARVYKTI in a dimly lit lab setting

May 10, 2026

Why Legend Biotech (LEGN) Is Up 21.5% After Expanding CARVYKTI Manufacturing And Scientific Advisory Board

Legend Biotech has made significant strides by expanding its scientific advisory board and increasing manufacturing capacity for CARVYKTI, a key cell therapy product. This move is expected to bolster the company’s capabilities in addressing unmet medical needs within oncology.The recent agreement with Janssen to enhance CARVYKTI manufacturing at their New Jersey facility is a strategic effort to align production with anticipated demand. This expansion not only aims to mitigate supply risks but a
A minimalist illustration of a pill against a solid background.

May 5, 2026

AI is saving pharma billions in manufacturing and back-office work, just not in the lab

The integration of AI in the pharmaceutical industry has yielded significant benefits, particularly in manufacturing and administrative operations, but its impact on drug discovery remains limited.Diogo Rau, the Chief Information and Digital Officer at Eli Lilly, recently highlighted that AI's effectiveness has not yet materialized in drug discovery, despite substantial investments in technology partnerships and infrastructure. Major pharmaceutical companies like Roche, GSK, AstraZeneca, and Mer